Background illustration for clinical trials search

Paid Clinical Trials Birmingham

Discover 901 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

for
Neoplasms, Endometrial
Location: Birmingham AL, Charlottesville VA, Sugar Land TX,
Sponsor: GlaxoSmithKline

Sex: Female

Age: 18+

Code: NCT07286331

Phase 3, Recruiting

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

for
Ulcerative Colitis, Crohn's Disease
Location: Birmingham AL, Atlanta GA, Mobile AL, Southaven MS,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06581328

Phase 4, Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Birmingham AL, Atlanta GA, Nashville TN,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase 2, Recruiting

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

for
Cancer
Location: Birmingham AL, Atlanta GA, Carterville IL,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT06207032

Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Birmingham AL, Atlanta GA, Corbin KY, Covington LA,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

GEMINI-NSCLC: NSCLC Biomarker Study

for
Non-Small Cell Lung Cancer
Location: Birmingham AL, Atlanta GA, Memphis TN, Carterville IL,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05236114

Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Birmingham AL, Atlanta GA, Nashville TN, Greenville SC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Birmingham AL, Huntsville AL, Newnan GA, Marietta GA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase 3, Recruiting

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

for
Pulmonary Embolism
Location: Birmingham AL, Knoxville TN, Chapel Hill NC,
Sponsor: Innova Vascular, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06041594

Recruiting

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

for
Atrial Fibrillation (AF), Persistant Atrial Fibrillation,
Location: Birmingham AL, Atlanta GA, Jonesboro AR, Lexington KY,
Sponsor: Arga Medtech SA

Sex: All

Age: 18 - 70+

Code: NCT06784466

Recruiting

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

for
Atrial Fibrillation
Location: Birmingham AL, Jonesboro AR, Edgewood KY, Atlantis FL,
Sponsor: Biosense Webster, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07527299

Recruiting

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

for
Paroxysmal Atrial Fibrillation
Location: Birmingham AL, Atlanta GA, Mobile AL, Louisville KY,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT06324201

Recruiting

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

for
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
Location: Birmingham AL, Louisville KY, Charlottesville VA,
Sponsor: Octapharma

Sex: All

Age: 2 - 17

Code: NCT04929236

Phase 3, Recruiting

Families Left Behind

for
Grief, Grief Disorder, Prolonged, Overdose Accidental,
Location: Birmingham AL, Farmington CT, San Diego CA
Sponsor: RAND

Sex: All

Age: 18+

Code: NCT06854757

Recruiting

Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics

for
Development of Clostridium Difficile Associated Diarrhea
Location: Birmingham AL
Sponsor: St. Vincent's East, Birmingham, Alabama

Sex: All

Age: 19+

Code: NCT01873872

Recruiting

FELLAShip to Better Health

for
High Blood Glucose, High Cholesterol,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Male

Age: 18+

Code: NCT07220213

Recruiting

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

for
Hidradenitis Suppurativa (HS)
Location: Birmingham AL, Montgomery AL, Marietta GA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06855498

Phase 3, Recruiting
New

Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis

for
Atopic Dermatitis, Atopic Dermatitis (AD),
Location: Birmingham AL, Bryant AR, Chicago IL, Miami Lakes FL
Sponsor: Arcutis Biotherapeutics, Inc.

Sex: All

Age: 6+

Code: NCT07916480

Phase 3, Recruiting

A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus

for
Lichen Sclerosus
Location: Birmingham AL, Jacksonville FL, Clearwater FL, Tampa FL,
Sponsor: LEO Pharma

Sex: All

Age: 18+

Code: NCT07335588

Phase 3, Recruiting

ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa (HS)
Location: Birmingham AL, Sandy Springs GA, Smyrna TN,
Sponsor: Oruka Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07783542

Phase 2, Recruiting